{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:00:59Z","timestamp":1774972859525,"version":"3.50.1"},"reference-count":44,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1454,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:p>Biphenotypic acute leukaemia (BAL) patients represented 8% of the 287 <jats:italic>de novo<\/jats:italic> consecutive adult acute leukaemias (23 BAL, 230 acute myeloid leukaemia (AML) and 34 acute lymphoblastic leukaemia (ALL)) referred to our department during the last 4\u2010year period. Of these 23 BAL patients, 14 patients showed myeloid morphology and nine cases lymphoid morphology according to FAB criteria. There were no differences between lymphoid and myeloid BAL according to clinical and biological presentation and treatment outcome. We confirm the poor prognosis of BAL when compared to AML or ALL seen during the same period of time, in terms of complete remission (47%, 62% and 82% respectively, BAL <jats:italic>v<\/jats:italic> AML, NS and BAL <jats:italic>v<\/jats:italic> ALL, <jats:italic>P<\/jats:italic>\u2003=\u20030.006) and 4\u2010year overall survival (8.1%, 25.8% and 23.8% respectively, BAL <jats:italic>v<\/jats:italic> AML, <jats:italic>P<\/jats:italic>\u2003=\u20030.05 and BAL <jats:italic>v<\/jats:italic> ALL, <jats:italic>P<\/jats:italic>\u2003=\u20030.003). Comparing adult BAL patients with AML patients, we found an increase in poor prognostic factors: CD34<jats:sup>+<\/jats:sup> phenotype (82% <jats:italic>v<\/jats:italic> 60% respectively, <jats:italic>P<\/jats:italic>\u2003=\u20030.03), unfavourable karyotype (60% <jats:italic>v<\/jats:italic> 20%, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001) and Pgp over\u2010expression by RT\u2010PCR (0.705 <jats:italic>v<\/jats:italic> 0.107, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001) and flow cytometry (0.824 <jats:italic>v<\/jats:italic> 0.391, <jats:italic>P<\/jats:italic>\u2003=\u20030.0001). MRP and LRP were not found to be poor prognostic factors. Comparing BAL patients with ALL patients, we found also an increase in poor prognostic factors: age (51 <jats:italic>v<\/jats:italic> 39, <jats:italic>P<\/jats:italic>\u2003=\u20030.003) and CD34<jats:sup>+<\/jats:sup> phenotype (82% <jats:italic>v<\/jats:italic> 50%, <jats:italic>P<\/jats:italic>\u2003=\u20030.02). We conclude that BAL patients need a more aggressive treatment procedure, including high\u2010dose AraC or the use of Pgp modulators for first\u2010line therapy.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1998.00523.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:57:57Z","timestamp":1047362277000},"page":"147-155","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P\u2010glycoprotein over\u2010expression"],"prefix":"10.1111","volume":"100","author":[{"given":"Ollivier","family":"Legrand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Yves","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghislaine","family":"Simonin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Baudard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Cadiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Ramond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Vigui\u00c9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Pierre","family":"Marie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Zittoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"799","article-title":"Lack of correlation between expression and function of Pgp in acute myeloid leukemia cells","volume":"9","author":"Bailly J.D.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.10.2242.2242"},{"key":"e_1_2_5_4_2","first-page":"3010","article-title":"Methods to detect P\u2010glycoprotein\u2010associated multidrug resistance in patient tumors: consensus recommendations","volume":"56","author":"Beck W.T.","year":"1996","journal-title":"Cancer Research"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1981.tb02684.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-4-620"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb04444.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(87)90216-0"},{"key":"e_1_2_5_9_2","first-page":"2118","article-title":"Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults: the Southwest Oncology Group Experience","volume":"8","author":"Boldt D.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_5_10_2","first-page":"919","article-title":"Lineage commitment in biphenotypic acute leukemia","volume":"7","author":"Buccheri V.","year":"1993","journal-title":"Leukemia"},{"issue":"1","key":"e_1_2_5_11_2","first-page":"S28","article-title":"The role of prognostic factors in acute myeloid leukemia","volume":"10","author":"B\u00fcchner T.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_5_12_2","first-page":"1283","article-title":"Cytogenetic findings in acute biphenotypic leukemia","volume":"10","author":"Carbonell F.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01714978"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1182\/blood.V79.3.720.720","article-title":"Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers","volume":"79","author":"Cuneo A.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_5_15_2","first-page":"49","article-title":"Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis","volume":"85","author":"Curtis A.H.","year":"1993","journal-title":"British Journal of Haematology"},{"key":"e_1_2_5_16_2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood.V67.4.1048.1048","article-title":"Expression of normal myeloid associated antigens by acute leukemia cells","volume":"67","author":"Dinndorf P.A.","year":"1986","journal-title":"Blood"},{"key":"e_1_2_5_17_2","first-page":"1419","article-title":"Multidrug resistance\u2010associated protein in acute myeloid leukemia: no impact on treatment outcome","volume":"3","author":"Filipits M.","year":"1997","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(84)80022-9"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.00254.x-i1"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb03024.x"},{"key":"e_1_2_5_21_2","first-page":"121","article-title":"Karyotypic patterns in acute mixed lineage leukemia","volume":"4","author":"Hayashi Y.","year":"1990","journal-title":"Leukemia"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.1.123.123"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050259"},{"key":"e_1_2_5_24_2","unstructured":"ISCN(1995)An International System for Human Cytogenetic Nomenclature(ed. by F. Mitelman). Karger Basel."},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood.V76.4.808.808","article-title":"Mixed\u2010lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxydase\u2010positive blasts by electron microscopy","volume":"76","author":"Kantarjian H.M.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_5_27_2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood.V80.2.470.470","article-title":"Phenotypical characteristics of acute myelocytic leukemia associated with t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B\u2010cell antigen CD19 together with stem cell antigen CD34","volume":"80","author":"Kita K.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1776.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.6.2464.bloodjournal8762464"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb00284.x"},{"key":"e_1_2_5_31_2","first-page":"1742","article-title":"Glutathione\u2010S\u2010transferases \u03c0, \u03bc and mdr1 mRNA expression in normal lymphocytes and chronic lymphocytic leukemia","volume":"9","author":"Marie J.\u2010P.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(96)00055-X"},{"key":"e_1_2_5_33_2","doi-asserted-by":"crossref","unstructured":"Noonan K.E.&Roninson I.B.(1991) Quantitative estimation of MDR1 mRNA levels by polymerase chain reaction.Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells(ed. by I. B. Robinson) pp.319333. Plenum Press New York.","DOI":"10.1007\/978-1-4615-3794-6_17"},{"key":"e_1_2_5_34_2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V75.1.198.198","article-title":"Myeloid\u2010associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy","volume":"75","author":"Pui C.H.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.11.3083.3083"},{"key":"e_1_2_5_36_2","first-page":"373","article-title":"Multiparameter analysis of acute mixed lineage leukemia: correlation of a B\/myeloid immunophenotype and immunoglobulin and T\u2010cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology","volume":"5","author":"Saikevych I.A.","year":"1991","journal-title":"Leukemia"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0695-578"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2053.x"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198704303161802"},{"issue":"2","key":"e_1_2_5_40_2","first-page":"199","article-title":"Therapy of adult ALL: overview of two successive EORTC studies (ALL2 and ALL3)","volume":"6","author":"Stryckmans P.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_5_41_2","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1182\/blood.V82.10.3157.3157","article-title":"Predominance of functional multidrug resistance (MDR\u20101) phenotype in CD34+ acute myeloid leukemia cells","volume":"82","author":"Te Boekhorst P.A.W.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02649.x"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/25.7.894009"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198409273111302"},{"key":"e_1_2_5_45_2","first-page":"1661","article-title":"Expression of multidrug resistance\u2010associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia","volume":"9","author":"Zhou D.C.","year":"1995","journal-title":"Leukemia"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00523.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00523.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2141.1998.00523.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00523.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T06:34:47Z","timestamp":1694414087000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1998.00523.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1046\/j.1365-2141.1998.00523.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1998.00523.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]},"assertion":[{"value":"2001-12-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}